Eriacta, comprising Sildenafil Citrate and identifiable by its distinctive blue tablets, is a pharmacotherapeutic agent employed in the management of erectile dysfunction (ED). The administration of this medication requires meticulous consideration, particularly in the context of patients presenting with advanced cardiovascular pathologies.